Guest guest Posted December 1, 2008 Report Share Posted December 1, 2008 Select the optimal management choice by clicking one of the answers below. The CME-certified case will then load, providing feedback on your selection and the opportunity to test your ability to manage this patient’s disease by continuing the case. CME Information | Learning Objectives | Disclosures Management of a 43-Year-Old HCV-Infected, Treatment-Naive Female With a History of Major Depression Faculty: L. Raison, MD The patient is a 43-year-old white female diagnosed with hepatitis C virus (HCV) infection 1 year ago after her internist ordered a screening test because of her relevant risk factors. Further laboratory analysis indicated infection with genotype 2b HCV and an HCV RNA level of 485,000 IU/mL. She is currently treatment naive. The patient likely contracted HCV from intravenous drug use in her early 20s, but she states that she has been abstinent from drugs and alcohol since she was 27 years of age. Her medical history is significant for a past history of major depression, with her first episode occurring at 32 years of age and lasting approximately 1 year. She had a second episode 3 years ago that was successfully treated with the selective serotonin reuptake inhibitor (SSRI) citalopram. She self-discontinued the antidepressant approximately 1 year ago. The patient presents requesting treatment of her HCV infection and is judged to be a good candidate for therapy given her moderate HCV RNA level (now measuring 542,000 IU/mL) and infection with genotype 2 HCV. During a follow-up visit before treatment is initiated, she confides to her nurse that she has “been losing sleep at night” worrying about her upcoming HCV treatment. When the physician asks her about this, she bursts into tears and says her husband is completely unsupportive of initiating HCV therapy and has been blaming her for contracting HCV in the first place. Click your choice below. You will enter the CME-certified program and get immediate feedback. Then you will be able to continue to manage this patient. Given this information, how would you manage the patient at this time? A. Screen for depressive symptoms before determining the next step B. Initiate treatment with an antidepressant before starting HCV therapy C. Begin HCV therapy Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC. Release date: September 9, 2008Expiration date: September 8, 2009 Supported by an educational grant from Schering-Plough. DisclaimerThe materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials. CCO Hepatitis | RSS | Hepatitis Podcasts | Bookstore | Slideset Downloads To ensure you receive Clinical Care Options educational materials by email,please add info@... to your contacts or address book. Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston White Drive, Suite 110, Reston, VA 20191-5433 Not a member yet? Click here | Unsubscribe from all emails sent from CCO | Manage email preferences Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 1, 2008 Report Share Posted December 1, 2008 Select the optimal management choice by clicking one of the answers below. The CME-certified case will then load, providing feedback on your selection and the opportunity to test your ability to manage this patient’s disease by continuing the case. CME Information | Learning Objectives | Disclosures Management of a 43-Year-Old HCV-Infected, Treatment-Naive Female With a History of Major Depression Faculty: L. Raison, MD The patient is a 43-year-old white female diagnosed with hepatitis C virus (HCV) infection 1 year ago after her internist ordered a screening test because of her relevant risk factors. Further laboratory analysis indicated infection with genotype 2b HCV and an HCV RNA level of 485,000 IU/mL. She is currently treatment naive. The patient likely contracted HCV from intravenous drug use in her early 20s, but she states that she has been abstinent from drugs and alcohol since she was 27 years of age. Her medical history is significant for a past history of major depression, with her first episode occurring at 32 years of age and lasting approximately 1 year. She had a second episode 3 years ago that was successfully treated with the selective serotonin reuptake inhibitor (SSRI) citalopram. She self-discontinued the antidepressant approximately 1 year ago. The patient presents requesting treatment of her HCV infection and is judged to be a good candidate for therapy given her moderate HCV RNA level (now measuring 542,000 IU/mL) and infection with genotype 2 HCV. During a follow-up visit before treatment is initiated, she confides to her nurse that she has “been losing sleep at night” worrying about her upcoming HCV treatment. When the physician asks her about this, she bursts into tears and says her husband is completely unsupportive of initiating HCV therapy and has been blaming her for contracting HCV in the first place. Click your choice below. You will enter the CME-certified program and get immediate feedback. Then you will be able to continue to manage this patient. Given this information, how would you manage the patient at this time? A. Screen for depressive symptoms before determining the next step B. Initiate treatment with an antidepressant before starting HCV therapy C. Begin HCV therapy Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC. Release date: September 9, 2008Expiration date: September 8, 2009 Supported by an educational grant from Schering-Plough. DisclaimerThe materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials. CCO Hepatitis | RSS | Hepatitis Podcasts | Bookstore | Slideset Downloads To ensure you receive Clinical Care Options educational materials by email,please add info@... to your contacts or address book. Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston White Drive, Suite 110, Reston, VA 20191-5433 Not a member yet? Click here | Unsubscribe from all emails sent from CCO | Manage email preferences Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.